Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Cell Cycle Checkpoints. Found 5 abstracts

Hahn NM, Necchi A, Loriot Y, Powles T, Plimack ER, Sonpavde G, Roupret M, Kamat AM. Role of Checkpoint Inhibition in Localized Bladder Cancer. European urology oncology. 2018 Aug;1(3):190-8.
Prudnikova TY, Villamar-Cruz O, Rawat SJ, Cai KQ, Chernoff J. Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells. Oncogene. 2016 Apr 28;35(17):2178-85.   PMCID: PMC5125076
Skala E, Sitarek P, Toma M, Szemraj J, Radek M, Nieborowska-Skorska M, Skorski T, Wysokinska H, Sliwinski T. Inhibition of human glioma cell proliferation by altered Bax/Bcl-2-p53 expression and apoptosis induction by Rhaponticum carthamoides extracts from transformed and normal roots. The Journal of pharmacy and pharmacology. 2016 Nov;68(11):1454-64.
Zibelman M, Plimack ER. Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm. Oncology (Williston Park). 2016 Feb;30(2):160-2, 176.
Kagawa S, Natsuizaka M, Whelan KA, Facompre N, Naganuma S, Ohashi S, Kinugasa H, Egloff AM, Basu D, Gimotty PA, Klein-Szanto AJ, Bass AJ, Wong KK, Diehl JA, Rustgi AK, Nakagawa H. Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities. Oncogene. 2015 Apr 30;34(18):2347-59.   PMCID: 4268095
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Cell Cycle Checkpoints

Cell Cycle Checkpoints pathology Signal Transduction Cell Proliferation metabolism drug therapy antagonists & inhibitors physiology drug effects genetics immunology Tumor Suppressor Protein p53 therapeutic use Programmed Cell Death 1 Receptor Carcinoma mortality CTLA-4 Antigen Mice pd-l1 Cyclin B1 Cell Aging Mitochondrial Membrane Potential Localized Urologic Neoplasms B7-H1 Antigen Bcl-2 and p53 gene expressions Translational Medical Research glioma primary cells isolation & purification bcl-2-Associated X Protein Cell Cycle Leuzea Proto-Oncogene Proteins c-bcl-2 Plant Extracts Non-muscle-invasive Glioma Urothelium enzymology Reverse Transcriptase Polymerase Chain Reaction Checkpoint inhibitor Drug Dose-Response Relationship Squamous Cell Carcinoma Phytotherapy biosynthesis Treatment Outcome ctla-4 Muscle-invasive Preclinical Drug Evaluation mitochondrial membrane potential cytology Notch1 Receptor Viral Proteins Cultured Cells epidemiology Esophagus Western Blotting Immunotherapy Molecular Targeted Therapy p21-Activated Kinases Rhaponticum carthamoides pharmacology Phosphorylation Retinoblastoma Protein Transforming Growth Factor beta Brain Neoplasms Bacterial Transformation Neoplastic Gene Expression Regulation Monoclonal Antibodies Urinary Bladder Neoplasms Viral Cell Transformation Cell Cycle Proteins Plant Roots Retrospective Studies Female Therapy apoptosis Diffusion of Innovation Phytogenic Antineoplastic Agents Xenograft Model Antitumor Assays Antineoplastic Agents Apoptosis Ovarian Neoplasms Protein Kinase Inhibitors Esophageal Neoplasms Fluorescence Microscopy Treatment chemistry Immunological Antineoplastic Agents Medicinal Plants Bladder cancer Transitional Cell Carcinoma pd-1 caffeic acid derivatives microbiology Keratinocytes Bax trends Agrobacterium
Last updated on Friday, August 07, 2020